Beyond LDL Cholesterol in Assessing Cardiovascular Risk: apo B or LDL-P?

被引：15
|
作者：
Master, Stephen R. [1 ,4 ]
Rader, Daniel J. [2 ,3 ,4 ]
机构：
[1] Univ Penn, Perelman Sch Med, Dept Pathol & Lab Med, Philadelphia, PA 19104 USA
[2] Univ Penn, Perelman Sch Med, Dept Med, Philadelphia, PA 19104 USA
[3] Univ Penn, Perelman Sch Med, Cardiovasc Inst, Philadelphia, PA 19104 USA
[4] Univ Penn, Perelman Sch Med, Inst Translat Med & Therapeut, Philadelphia, PA 19104 USA
来源：
CLINICAL CHEMISTRY | 2013年 / 59卷 / 05期
关键词：
HIGH-DENSITY-LIPOPROTEIN; DISEASE; METAANALYSIS; PREDICTION; MARKERS;
D O I：
10.1373/clinchem.2013.203208
中图分类号：
R446 [实验室诊断]; R-33 [实验医学、医学实验];
学科分类号：
1001 ;
摘要：
引用
收藏
页码：723 / 725
页数：3
相关论文
共 50 条
  • [41] LDL cholesterol in early pregnancy and offspring cardiovascular disease risk factors
    Christensen, Jacob J.
    Retterstol, Kjetil
    Godang, Kristin
    Roland, Marie Cecilie Paasche
    Qvigstad, Elisabeth
    Bollerslev, Jens
    Ueland, Thor
    Henriksen, Tore
    Holven, Kirsten B.
    JOURNAL OF CLINICAL LIPIDOLOGY, 2016, 10 (06) : 1369 - 1378
  • [42] Cardiovascular Risk: Not only does LDL-Cholesterol pay off
    Franke, Katharina
    AKTUELLE KARDIOLOGIE, 2018, 7 (02) : 103 - +
  • [43] Time Course of LDL Cholesterol Exposure and Cardiovascular Disease Event Risk
    Domanski, Michael J.
    Tian, Xin
    Wu, Colin O.
    Reis, Jared P.
    Dey, Amit K.
    Gu, Yuan
    Zhao, Lihui
    Bae, Sejong
    Liu, Kiang
    Hasan, Ahmed A.
    Zimrin, David
    Farkouh, Michael E.
    Hong, Charles C.
    Lloyd-Jones, Donald M.
    Fuster, Valentin
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2020, 76 (13) : 1507 - 1516
  • [44] LDL cholesterol is not a good marker of cardiovascular risk in Type 1 diabetes
    Hero, C.
    Svensson, A-M.
    Gidlund, P.
    Gudbjornsdottir, S.
    Eliasson, B.
    Eeg-Olofsson, K.
    DIABETIC MEDICINE, 2016, 33 (03) : 316 - 323
  • [45] Lowering LDL cholesterol reduces cardiovascular risk independently of presence of inflammation
    Storey, Benjamin C.
    Staplin, Natalie
    Haynes, Richard
    Reith, Christina
    Emberson, Jonathan
    Herrington, William G.
    Wheeler, David C.
    Walker, Robert
    Fellstrom, Bengt
    Wanner, Christoph
    Landray, Martin J.
    Baigent, Colin
    KIDNEY INTERNATIONAL, 2018, 93 (04) : 1000 - 1007
  • [46] Analyzing IMPROVE-IT Beyond LDL Cholesterol
    Makhmudova, Umidakhon
    Luetjohann, Dieter
    Schulze, P. Christian
    Davis, Harry R.
    Weingaertner, Oliver
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2022, 79 (04) : E151 - E152
  • [47] LDL cholesterol control in patients with very high cardiovascular risk. A simplified algorithm for achieving LDL cholesterol goals "in two steps"
    Guijarro-Herraiz, Carlos
    Masana-Marin, Luis
    Galve, Enrique
    Cordero-Fort, Alberto
    CLINICA E INVESTIGACION EN ARTERIOSCLEROSIS, 2014, 26 (05): : 242 - 252
  • [48] Excess cardiovascular risk in patients with type 2 diabetes: do we need to look beyond LDL cholesterol?
    Rees, Alan
    BRITISH JOURNAL OF DIABETES AND VASCULAR DISEASE, 2014, 14 (01): : 10 - 20
  • [49] Effect of absolute reduction in LDL cholesterol on cardiovascular events: Does final LDL cholesterol acheived matter?
    Rahilly, C. R.
    Gaziano, J.
    Scranton, R.
    VALUE IN HEALTH, 2006, 9 (06) : A340 - A341
  • [50] Non-HDL-cholesterol and apolipoprotein B compared with LDL-cholesterol in atherosclerotic cardiovascular disease risk assessment
    Carr, Stuart S.
    Hooper, Amanda J.
    Sullivan, David R.
    Burnett, John R.
    PATHOLOGY, 2019, 51 (02) : 148 - 154
12345